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Abstract
Background & Aims: Point mutations in the coding region of the interleukin 28 gene (rs12979860) have recently been
identified for predicting the outcome of treatment of hepatitis C virus infection. This polymorphism detection was based on
whole blood DNA extraction. Alternatively, DNA for genetic diagnosis has been derived from buccal epithelial cells (BEC),
dried blood spots (DBS), and genomic DNA from serum. The aim of the study was to investigate the reliability and accuracy
of alternative routes of testing for single nucleotide polymorphism allele rs12979860CC.
Methods: Blood, plasma, and sera samples from 200 patients were extracted (400 mL). Buccal smears were tested using an
FTA card. To simulate postal delay, we tested the influence of storage at ambient temperature on the different sources of
DNA at five time points (baseline, 48 h, 6 days, 9 days, and 12 days)
Results: There was 100% concordance between blood, plasma, sera, and BEC, validating the use of DNA extracted from BEC
collected on cytology brushes for genetic testing. Genetic variations in HPTR1 gene were detected using smear technique in
blood smear (3620 copies) as well as in buccal smears (5870 copies). These results are similar to those for whole blood
diluted at 1/10. A minimum of 0.04 mL, 4 mL, and 40 mL was necessary to obtain exploitable results respectively for whole
blood, sera, and plasma. No significant variation between each time point was observed for the different sources of DNA.
IL28B SNPs analysis at these different time points showed the same results using the four sources of DNA.
Conclusion: We demonstrated that genomic DNA extraction from buccal cells, small amounts of serum, and dried blood
spots is an alternative to DNA extracted from peripheral blood cells and is helpful in retrospective and prospective studies
for multiple genetic markers, specifically in hard-to-reach individuals.
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Introduction
Recent studies have demonstrated that host genetics may be
useful for predicting the spontaneous clearance of hepatitis C virus
during acute hepatitis and the drug response to peginterferon and
ribavirin in chronic hepatitis C [1,2,3,4,5,6,7,8]. The IL28B
promoter polymorphism at position -3176 C/T (rs12979860)
correlates with a significantly higher rate of spontaneous clearance
of the hepatitis C virus (HCV). Individuals with the CC genotype
have a two-fold higher sustained virological response (SVR, 55–
80%) with peginterferon and ribavirin than those with the CT or
TT genotype (SVR, 20–40%) [4,9].
However, all the IL28B-based studies used whole blood DNA
extraction for SNP analysis. DNA circulates freely in blood
plasma both in health and in disease, but the source of this DNA
remains enigmatic. It is presumed that circulating DNA in
healthy subjects is derived from lymphocytes or other nucleated
cells [10]. There are several methods for preparing genomic
DNA serum, some requiring very small amounts of serum (20–
250 mL) [11,12,13]. Indeed, DNA for genetic diagnosis has been
derived from finger-stick blood samples and genomic DNA from
serum roots, cheek scrapings, and urine samples. Oral saline
rinses have also been used extensively to collect buccal epithelial
cells as a DNA source.
The aim of this study was to investigate the reliability and
accuracy of alternative routes of sampling for genetic testing,
whether DNA from serum, buccal epithelial cells (BEC), or dried
blood spots (DBS) for SNP allele (rs12979860 CC) and to blindly
compare these results with those obtained with DNA extracted
from whole blood as reference.
Materials and Methods
Two hundred patients with chronic hepatitis C infection
genotype 1 were included from three hepatology units in the
south of France (two centres in Marseille and one in Saint Laurent
du Var). Mean age was 56611 years; there were 42 (21%) naı ¨ve
patients and 40 (20%) non responders. In whole blood, 59 (30%)
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CT genotype, and 34 (17%) had rs12979860 TT genotype.
Written informed consent including for genetic testing was
mandatory for inclusion. This study was approved by the French
ethics committee ‘‘Comite ´ de Protection des Personnes Sud-
Me ´diterrane ´e II’’ and had the reference number 210R22.
DBS Preparation
The DBS sample consisted of three drops of 50 mL of whole
blood absorbed onto a Protein Saver 903 Card (Whatman, Dassel,
Germany) to completely fill 12-mm preprinted circular paper disks
and then stored at room temperature. The FTA range of products
has been developed to collect, store, and extract nucleic acid from
many sample types, including blood, plasma/sera, and buccal
smears. After application of the sample to the FTA card,
microorganisms are inactivated, cell membranes lysed, and nucleic
acids entrapped onto the FTA matrix.
Genomic DNA extraction
Blood, plasma, and sera samples were extracted with a
MagNA Pure device (Roche) according to manufacturer
recommendations; 400 mLo fe a c hs a m p l et y p ew e r eu s e d .B l o o d
and buccal smears were tested on Whatman system (FTA card
and EasyCollect system, respectively). All sampling and tests
were performed simultaneously and the amount of DNA was
sufficient for molecular analysis. The study design is presented in
Figure 1.
EasyCollect system
Cells are captured on the foam applicator by swabbing the oral
mucosa and then transferred to indicating FTA Cards [14,15].
Sample Processing and DNA Quantification
To test the performance of the different systems, we used CELL
Control r-gene (Argene, Verniolle, France) on a Light Cycler 480
II (Roche) according to manufacturer recommendations. The
CELL Control r-gene
TM is a ready-to-use premix designed to
validate results obtained by real time amplification checking the
presence of cells on extracted samples. CELL Control r-gene
TM
determines the number of cells in the sample by quantifying the
HPRT1 gene (hypoxanthin phospho-ribosyl transferase) using
standards included in the kit. The HPRT1 gene is a housekeeping
gene for normalizing gene expression [16].
Influence of storage at ambient temperature
To simulate postal delay, we assessed the influence of storage at
ambient temperature on the different sources of DNA (BEC, DBS,
whole blood, and plasma). Ten patients were prospectively
sampled and their corresponding sources of DNA were tested
after storage at ambient temperature at five time points (baseline,
48 h, 6 days, 9 days, and 12 days). The stability of HPRT1 gene
quantification and the IL28B SNPs on BEC, DBS, and plasma
was also investigated at these different time points. Whole blood
served as a reference source of DNA.
Testing for IL28B SNPs
The rs12979860 SNPs were analysed in a Fret 59 allelic
discrimination assay using the Roche ‘LightCyclerH FastStart
DNA Master HybProbe’ with the LightCyclerH 1.x/2.0/480
Instruments [9]. A 139-bp-long fragment is amplified with specific
primers and analysed in a subsequent melting curve analysis, using
a SimpleProbe oligomer specific for the -3176 C allele. The
resulting PCR fragments are analysed with a SimpleProbeH in
channel 530. The genotypes are identified by running a melting
curve with specific melting points (Tm). The wild-type allele T
exhibits a Tm of 51.4uC (capillary) or 55uC (plate) while the
protective allele variant C shows a significant up shift of 8uC. The
melting temperature PCR results are obtained within 50 min (45
cycles and melting curve) with the LightCyclerH 1.x/2.0
Instruments and within 80 min (45 cycles and melting curve) with
the LightCyclerH 480 Instruments.
Statistical Analysis
Statistical analyses were performed using SAS software (SAS
9.1.3, SAS institute Inc. Cary, NC). Wilcoxon paired test was used
to compare results between whole blood, serum, DBS, and BEC.
Significance level was set at P,0.05.
Results
There was 100% concordance in detecting DNA between
blood, plasma, sera, and BEC. Regarding the sensitivity of DNA
detection of the different samplings, with reference the whole
Figure 1. Study Design.
doi:10.1371/journal.pone.0033000.g001
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plasma.
Sample HPRT1 Gene – Median [Range] (Copies) DNA – Median [Range] (ng) DNA – Median [Range] (fg)
Blood
No dilution 96900 [95000–98800] 0.006406 [0.006280–0.006532] 6406 [6280–6532]
Dilution 1/10 9763 [9100–10426] 0.0006455 [0.0006016–0.0006893] 646 [602–689]
Dilution 1/100 686 [590–782] 4.535335E-05 [3.9E-05–5.17E-05] 45.4 [39–51.7]
Dilution 1/1000 27.9 [26.2–29.6] 1.84455E-06 [1.73E-06–1.96E-06] 1.84 [1.73–1.96]
Dilution 1/10000 1.85 [1.75–1.95] 1.22309E-07 [1.16E-07–1.29E-07] 0.122 [0.116–0.129]
Sera
No dilution 66.9 [52.3–81.5] 4.42296E-06 [3.46E-06–5.39E-06] 4.423 [3.46–5.39)
Dilution 1/10 7.63 [5.40–9.86] 5.04442E-07 [3.57E-07–6.51E-07] 0.504 [0.357–0.651]
Dilution 1/100 0.228 [0.180–0.276] 1.50738E-08 [1.19E-08–1.82E-08] 0.015 [0.0119–0.0182]
Dilution 1/1000 Not detected Not detected Not detected
Dilution 1/10000 Not detected Not detected Not detected
Plasma
No dilution 10.9 [9.9–11.9] 7.20631E-07 [6.54E-07–7.87E-07] 0.721 [0.654–0.787)
Dilution 1/10 0.996 [0.852–1.140] 6.58485E-08 [5.63E-08–7.54E-08] 0.0658 [0.0563–0.0754]
Dilution 1/100 Not detected Not detected Not detected
Dilution 1/1000 Not detected Not detected Not detected
Dilution 1/10000 Not detected Not detected Not detected
Blood smear (FTA card) 3620 [3230–4010] 0.0002393 [0.0002135–0.0002651] 239 [214–265]
Buccal smear (EasyCollect) 5870 [5690–6050] 0.0003881 [0.0003762–0.0004000] 388 [376–400]
Blood, sera, and plasma were successively diluted at 10, 100, 1000, and 10000 in PBS. 400 mL of each type of sample were extracted with MagnaPur and eluted in 100 mL
of elution buffer. A minimum of 0.04 mL, 4 mL, and 40 mL was necessary to obtain exploitable results respectively for whole blood, sera, and plasma.
doi:10.1371/journal.pone.0033000.t001
Figure 2. Threshold for DNA detection among different sampling types.
doi:10.1371/journal.pone.0033000.g002
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(Table 1 and Figure 2).
Genetic variations in the HPTR1 gene were detected using
smear technique in blood smear (3620 copies) as well as in buccal
smears (5870 copies). These results are similar to those for whole
blood diluted at 1/10.
As 400 mL of each type of sample were extracted with
MagnaPur, a minimum of 0.04 mL, 4 mL, and 40 mL was
necessary to obtain exploitable results respectively for whole
blood, sera, and plasma (Table 1).
Figure 3 (A,B,C,D) presents the evolution of HPRT1 gene
quantification for buccal smears, DBS, whole blood, and plasma
samples after storage at ambient temperature at five time points
(baseline, 48 h, 6 days, 9 days, and 12 days). No significant
variation between each time point (P.0.05, Wilcoxon paired test)
was observed for the different sources of DNA.
IL28B SNPs analysis at these different time points showed the
same results using the four source of DNA (Table 2).
Discussion
Our study is the first to prospectively compare and validate
different DNA sampling sources. Results show that plasma, serum,
BEC, or DBS can be used as a source of DNA for IL28B
genotyping, with full concordance (100% of sensitivity) with whole
blood DNA extraction. The various extraction procedures gave
identical SNP genotypes, which confirms that genomic DNA
prepared from small amounts of serum or plasma can serve as a
template to amplify DNA segments in order to detect genetic
alterations, as described by Lin and Floros [11]. Moreover, this
study determined the minimal quantity of sera and plasma to be
used (4 mL and 40 mL respectively) to reach the cut-off of
sensitivity of detection.
It is important to recall that the stability and integrity of
genomic DNA depend on storage conditions such as temperature,
freeze-thaw cycles, and buffer composition. We observed no
influence of storage conditions at ambient temperature, incidently
showing postal delay in DNA sample shipping may be avoided.
There was no difference in DNA from baseline to 12 days for the
different sources of DNA tested (BEC, DBS, whole blood, and
plasma). FTA cards, plasma, and sera are appropriate tools for
clinical study because of their long term DNA conservation.
The combination of a micro-extraction procedure from serum
and PCR genotyping provides a rapid and inexpensive tool for
genetic analysis [17]. A small amount of serum (250 mL) can be
very informative, since it yields enough DNA to analyse several
genetic markers. Note that plasma or serum is more reliable than
whole blood for clinical studies, specifically for retrospective
studies based on stored DNA and for shipment of sera in clinical
trial analysis with centralised laboratories [18]. The present study
also evidenced the possibility of using DNA from serum and
plasma to simulate serum or plasma utilization for DNA analysis of
stored samples.
Cancer patients have a greater amount of circulating DNA than
healthy subjects [19]. It seems unlikely that tumoural DNA
originates from the lysis of circulating cancer cells because the
number of circulating cells usually found in plasma is not high
enough to explain the large amount of DNA detected [20].
Apoptosis has been proposed as the origin of circulating DNA, but
this mechanism is thought to be lost by proliferating cells [21].
As an alternative to the usual venipuncture technique, several
methods have been described that use DBS from finger-puncture
Figure 3. Evolution of HPTR1 gene quantification (Log10 Copies) for buccal smears (3A), DBS (3B), whole blood (3C), and plasma
(3D) samples after storage at ambient temperature at five time points (baseline, 48 h, 6 days, 9 days, and 12 days).
doi:10.1371/journal.pone.0033000.g003
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mucosa cell sampling is almost completely non-invasive and
painless, reducing compliance issues. Samples collected generate
DNA usable after shipment through conventional mail [26].
Sample collection does not require highly trained personnel or an
established ‘cold chain’ to preserve samples until DNA is
extracted. FTA
TM cards are a viable storage matrix from DNA,
and can be extracted to perform Genome Wide Analysis Studies
analysis (GWAS) [18]. Moreover, GWAS are commonly used to
identify genetic predispositions of many human diseases. Large
repositories of biological specimens for clinical and genetic
investigations have been established to store material and data
for these studies.
Another important issue is that, ideally, tissue sampling should
be non-invasive and painless, especially for children and
psychiatric groups. Preparation of DNA also needs to be rapid,
reliable, and consistent. In any large-scale genetic association
project, per-unit cost of DNA preparation becomes high. Also,
DNA sample collection is needed in genotyping and in
pharmacogenetic studies to understand the inter-individual
variability of drug responses.
We also analysed patients’ acceptability of the various sampling
conditions. Buccal smear had an excellent and acceptability rate,
the highest compared with serum and dried blood spot (data not
shown).
In conclusion, we report that extracting genomic DNA from
small amounts of serum, DBS, and BEC is an appropriate
alternative to extracting DNA from peripheral blood cells and
offers the possibility to analyse existing specimens. New patterns in
genetic markers might be considered using serum as DNA source.
DNA cards clearly facilitate genetic and pharmacogenetic testing
for routine clinical practice. Moreover, collection and extraction of
DNA from buccal smear are a noninvasive, convenient, and cost-
effective alternative to blood sampling for participants and
researchers, and can be mailed out for self-collection, overcoming
geographical impediments. For patients with chronic hepatitis C
infection, treatment response may be established through large
screening for personalized medicine.
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